Treated by 177LUTETIUM-PSMA-617 (lu-PSMA)

Clinical trials for Treated by 177LUTETIUM-PSMA-617 (lu-PSMA) explained in plain language.

Never miss a new study

Get alerted when new Treated by 177LUTETIUM-PSMA-617 (lu-PSMA) trials appear

Sign up with your email to follow new studies for Treated by 177LUTETIUM-PSMA-617 (lu-PSMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New study aims to predict which prostate cancer patients benefit from Lu-PSMA therapy

Knowledge-focused Recruiting now

This study is looking for genetic clues in tumor tissue that could predict whether Lu-PSMA treatment will be effective for men with advanced, castration-resistant prostate cancer. About 120 men who have already tried other treatments will provide tumor samples for analysis. The g…

Matched conditions: TREATED BY 177LUTETIUM-PSMA-617 (LU-PSMA)

Sponsor: Centre Jean Perrin • Aim: Knowledge-focused

Last updated Jun 27, 2026 08:07 UTC

Treated by 177LUTETIUM-PSMA-617 (lu-PSMA)

Get alerted when new Treated by 177LUTETIUM-PSMA-617 (lu-PSMA) trials appear

New study aims to predict which prostate cancer patients benefit from Lu-PSMA therapy